SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Business
CNS Pharmaceuticals Announces Appointment of Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute, to Science Advisory Board
August 27, 2020
 · 
4 min read
Lone Star Bio
CNS Provides FDA Update on IND Filing
August 25, 2020
 · 
5 min read
Business
CNS Pharmaceuticals Engages CRO For Phase 2 Berubicin Clinical Trials
August 20, 2020
 · 
6 min read
Job Trends
CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020
August 11, 2020
 · 
2 min read
Lone Star Bio
CNS Pharmaceuticals Recognizes Glioblastoma Awareness Day
July 22, 2020
 · 
6 min read
Lone Star Bio
CNS Pharmaceuticals Completes Drug Product Manufacturing Strategy for Berubicin
July 15, 2020
 · 
4 min read
Lone Star Bio
CNS Pharmaceuticals Completes Active Ingredient Shipments to Manufacturers
July 8, 2020
 · 
4 min read
Drug Development
CNS Pharmaceuticals Engages Berry Consultants to Advise Phase 2 Trial Design
June 30, 2020
 · 
4 min read
Lone Star Bio
CNS To Present at the Life Sciences Investor Forum
June 23, 2020
 · 
3 min read
Job Trends
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
June 11, 2020
 · 
5 min read
Load More
JOBS